CTOs on the Move

Catalyst OrthoScience

www.catalystortho.com

 
At Catalyst OrthoScience, our goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients. Catalyst OrthoScience was founded by a board-certified orthopedic surgeon and is comprised of a team of biomedical industry professionals with more than 100 years of combined medical device experience. The Catalyst CSR Total Shoulder System is the result of the visionary insight of Steven Goldberg, M.D., a fellowship-trained orthopedic surgeon and shoulder specialist, who devised the next generation, higher precision, less-invasive total shoulder solution with a greatly simplified method of implant placement. The key design elements of ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Catalyst OrthoScience raised $12.7M on 05/14/2019

Similar Companies

IBP MEDICAL

IBP MEDICAL is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Surgipath Medical Industries

Surgipath Medical Industries is a worldwide leader in the development, manufacture and supply of quality product solutions for the Anatomical Pathology Laboratory. Since we were founded, our fundamental business strategies ensure our customer's

DiaMed

DiaMed is a Canton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Warner Tech-Care Products

Warner Tech-Care Products is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osprey Medical

Osprey Medical is a medical device company incorporated in 2005 with operations based in Minnetonka, Minnesota, USA. The Company is focused on protecting patients from the harmful effects of X-ray dye (contrast) used during commonly performed angiographic imaging procedures. Its proprietary dye reduction and monitoring technologies are designed to help physicians minimize dye usage. Osprey Medical`s core technologies originated from research conducted by Dr. David Kaye at Melbourne`s Baker IDI Heart and Diabetes Institute